Regis Healthcare (REG) Fundamentals 2026 — P/E 48.2x, Revenue Analysis | SniperIQ
Regis Healthcare (REG) is a AU-listed Healthcare company in Medical - Care Facilities with a market capitalization of A
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Regis Healthcare's market cap?
Regis Healthcare (REG) has a market capitalization of approximately A
What is Regis Healthcare's P/E ratio?
Regis Healthcare's trailing twelve-month P/E ratio is 48.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Regis Healthcare?
Regis Healthcare runs a net profit margin of 3.0%, a gross margin of 11.2%, and an operating margin of 3.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Regis Healthcare generate?
Regis Healthcare reported revenue of A
Does Regis Healthcare pay a dividend?
Regis Healthcare offers a trailing dividend yield of about 2.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Regis Healthcare financially healthy?
Regis Healthcare carries a debt-to-equity ratio of -0.27x and a current ratio of 0.09x, with a market beta of 0.83. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Regis Healthcare a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Regis Healthcare (REG) the key facts are: market cap A
Track Regis Healthcare's full fundamentals live
Get Regis Healthcare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.